Search Results for: fda

Stem cell tourism disaster coming: my case for caution

stem-cell-tourism-tumor

Stem Cell Tourism is a blanket term now used to refer to patients receiving non-FDA approved stem cell treatments either by traveling here within the U.S. or more often outside the U.S. Clinics are sprouting up all over the world offering treatments based on stem cells. The science behind these is often non-existent. Most stem […]

Stem cell tourism disaster coming: my case for caution Read More »

Stem cell tourism: from bad to worse from 2010-2011

Irv Weissman, immune rejuvenation

At last year’s ISSCR 2010 Meeting in San Francisco, President Irv Weissman talked about the dangers of unvalidated stem cell treatments. He talked about the responsibility of stem cell scientists to stand against these and the importance for scientists not to endorse or serve on advisory committees of companies peddling such products and “therapies”. As

Stem cell tourism: from bad to worse from 2010-2011 Read More »

Advanced Cell Technology and Geron: allies or competitors?

Geron-300x2212

Two companies, Advanced Cell Technology (ACT) and Geron, both HQ’d here in California, have FDA-approved early stage clinical trials in the works. Geron’s trial has already started and reportedly now has enrolled at least two patients. The trial is of course for the safety of Geron’s GRNOPC1 oligodendrocyte product made from human ES cells for

Advanced Cell Technology and Geron: allies or competitors? Read More »

Stem cell sports medicine: Bartolo Colon

There has been a lot of publicity about the reported stem cell treatment of NY Yankees pitcher Bartolo Colon.  According to several sources, Colon received his treatment in his native Dominican Republic. Major League Baseball reportedly seems most concerned about this case, at least publicly, because human growth hormone (hGH) might have been used in

Stem cell sports medicine: Bartolo Colon Read More »

Stem Cell Clinical Trials Part I: Geron VP Lebkoswki speaking today in Seattle

Geron-300x2212

We’ve all been closely following Geron and its work on ES cells. This morning there was a fantastic session here at the ASGCT meeting in Seattle on Clinical Trials on Stem Cells. Talk by Geron One of the speakers was Geron VP, Jane Lebkoswki, PhD: Development of Human Embryonic Stem Cell-Based Therapies for Treatment of

Stem Cell Clinical Trials Part I: Geron VP Lebkoswki speaking today in Seattle Read More »

CIRM funds $25 million for Geron trial, $38 million for basic biology

Geron-300x2212

CIRM announced two sets of awards today that both should make major impact including its first clinical trial via Geron and $38 million for 27 basic biology studies. First Clinical Trial. Today CIRM awarded $25 million to support Geron’s FDA-approved clinical trial for spinal cord injury. This is CIRM’s first award to a for-profit company

CIRM funds $25 million for Geron trial, $38 million for basic biology Read More »